FDA Inspection
NorMedNorMed – FDA Inspection, May 29, 2025
Record Details
This FDA Inspection record concerns NorMed, with an inspection on May 29, 2025, issued by the Seattle District Office, covering human drugs.
View Company Profile
ID · 8a23a124-f93d-4eeb-b277-14a69306095d
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1271198
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
FDA Citations
2- 21 CFR 211.142(b)Storage under appropriate conditions
- 21 CFR 211.84(d)(2)Reports of Analysis (Components)
Full citation text and observation details available on the Dashboard.
Other FDA inspections of NorMed
3| Date | Classification | Office | Project area |
|---|---|---|---|
| January 16, 2018 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| December 12, 2012 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| June 22, 2011 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for NorMed
- FDA Inspection 1037662 - 2018-01-16
- FDA Inspection 809893 - 2012-12-12
- FDA Inspection 734357 - 2011-06-22
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.